Corrigendum: A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors

Shawn Iadonato; Yulia Ovechkina; Kurt Lustig; Jessica Cross; Nathan Eyde; Emily Frazier; Neda Kabi; Chen Katz; Remington Lance; David Peckham; Shaarwari Sridhar; Carla Talbaux; Isabelle Tihista; Mei Xu; Thierry Guillaudeux

doi:10.3389/fimmu.2024.1365240

Corrigendum: A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors

Front Immunol. 2024 Jan 23:15:1365240. doi: 10.3389/fimmu.2024.1365240. eCollection 2024.

Affiliation

¹ Kineta Inc., Seattle, WA, United States.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1311658.].

Keywords: B7-H5; PD-1 combination therapy; PD-1H; Vista; immune checkpoint inhibitor; immunotherapy; poorly immunogenic tumors; tumor microenvironment immunosuppression.

Publication types

Published Erratum